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Abstract
Background: Multidrug resistance (MDR) is a major clinical problem in tertiary hospitals in Tanzania and jeopardizes the life
of neonates in critical care units (CCUs). To better understand methods for prevention of MDR infections, this study aimed to
determine, among other factors, the role of MDR-Gram-negative bacteria (GNB) contaminating neonatal cots and hands of
mothers as possible role in transmission of bacteremia at Bugando Medical Centre (BMC), Mwanza, Tanzania.
Methods: This cross-sectional, hospital-based study was conducted among neonates and their mothers in a neonatal
intensive care unit and a neonatology unit at BMC from December 2018 to April 2019. Blood specimens (n= 200) were sub-
cultured on 5% sheep blood agar (SBA) and MacConkey agar (MCA) plates. Other specimens (200 neonatal rectal swabs, 200
maternal hand swabs and 200 neonatal cot swabs) were directly inoculated on MCA plates supplemented with 2 μg/ml
cefotaxime (MCA-C) for screening of GNB resistant to third generation cephalosporins, r-3GCs. Conventional biochemical
tests, Kirby-Bauer technique and resistance to cefoxitin 30 μg were used for identification of bacteria, antibiotic susceptibility
testing and detection of MDR-GNB and screening of potential Amp-C beta lactamase producing GNB, respectively.
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Results: The prevalence of culture confirmed bacteremia was 34.5% of which 85.5% were GNB. Fifty-five (93.2%) of GNB
isolated from neonatal blood specimens were r-3GCs. On the other hand; 43% of neonates were colonized with GNB r-
3GCs, 32% of cots were contaminated with GNB r-3GCs and 18.5% of hands of neonates’mothers were contaminated with
GNB r-3GCs. The prevalences of MDR-GNB isolated from blood culture and GNB r-3GCs isolated from neonatal colonization,
cots and mothers’ hands were 96.6, 100, 100 and 94.6%, respectively. Significantly, cyanosis (OR[95%CI]: 3.13[1.51–6.51], p=
0.002), jaundice (OR[95%CI]: 2.10[1.07–4.14], p= 0.031), number of invasive devices (OR[95%CI]: 2.52[1.08–5.85], p = 0.031) and
contaminated cot (OR[95%CI]: 2.39[1.26–4.55], p= 0.008) were associated with bacteremia due to GNB. Use of tap water only
(OR[95%CI]: 2.12[0.88–5.09], p= 0.040) was protective for bacteremia due to GNB.
Conclusion: High prevalence of MDR-GNB bacteremia and intestinal colonization, and MDR-GNB contaminating cots
and mothers’ hands was observed. Improved cots decontamination strategies is crucial to limit the spread of MDR-
GNB. Further, clinical presentations and water use should be considered in administration of empirical therapy whilst
awaiting culture results.
Keywords: Antimicrobial resistance, Hand hygiene, Hospital surfaces contamination, Multidrug resistant bacteria,
Bacteremia
Background
Multidrug resistance (MDR) is defined as acquired resistance
to at least one agent in three or more antimicrobial classes
[1–3]. MDR is a growing global concern which is estimated
to cause 10 million deaths and cost US$100 trillion annually
by 2050 [4, 5]. Improper use of antibiotics in human and vet-
erinary medicine, counterfeit antibiotics and non-compliant
use of rationally prescribed antibiotics are among factors
driving the emergence and spread of MDR bacteria [6]. High
antibiotic pressure (empirically prescribed and administered)
in the critical care units (intensive care units and neonat-
ology units) results in the selection and emergence of MDR
bacteria [7, 8]. The spread of MDR bacteria in healthcare set-
tings presents a challenge, as treating infected patients be-
comes increasingly difficult with poorer outcomes [6]. MDR
Gram-negative bacteria (MDR-GNB) such as beta-lactamase
(extended spectrum beta-lactamase (ESBL), Amp-C beta-
lactamase and carbapenemases) producing Enterobacteria-
ceae, Acinetobacter baumannii and Pseudomonas aeruginosa
are frequently reported, causing infections in critical care
units globally [9–12]. These organisms are responsible for
bloodstream infections (BSIs), urinary tract infections (UTIs),
pneumonia, and skin and soft tissue infections, resulting in
high morbidity and mortality [13].
In critical care units, infections due to MDR-GNB bac-
teria may be acquired endogenously or exogenously [14].
Endogenous acquisition occurs from the patient’s own
body flora colonizing a certain body surface, for ex-
ample, MDR-GNB colonizing patient’s gastrointestinal
tract (such as MDR-E. coli) may cause an extra-
intestinal infection (e.g., BSI and UTI) which may even
result to mortality from treatment failure [14, 15]. Ex-
ogenous acquisition occurs due to contact with other
people e.g., healthcare workers (HCWs), patients or care
givers (CGs) i.e., mothers; and/or contaminated surfaces,
such as ventilators, beds, side tables and infusion stands,
and water sources [14, 16]. Contaminated patients’ envi-
ronments with MDR-GNB increases the risk of exogen-
ous acquire of healthcare associate infections (HCAIs)
from MDR-GNB which are mostly cross-transmitted by
contaminated hands of HCWs and CGs [17]. Hands of
HCWs and CGs become contaminated when touching
contaminated surfaces and even colonized patients dur-
ing provision of medical care [18].
In Mwanza, Tanzania, 10.5 to 49% of bacteremia cases
due to GNB are caused by MDR-GNB with mortality rate
ranging from 34.4 to 52% as compared to mortality with
none MDR-GNB which ranging from 16.2 to 25% [11, 19,
20]. Rectal colonization of neonates with extended-
spectrum beta-lactamase producing Enterobacteriaceae
(ESBL-PE) is common (25.4 to 54.6%) [19, 20], as is con-
tamination of the hospital’s inanimate surfaces (33.5%) [21].
In Tanzania, it is common that, mothers play an important
role in feeding and caring for hospitalized neonates. To
date, their role in infection transmission or prevention has
not been considered. To reduce the incidence and improve
the management of MDR-GNB cases in the neonatal ICU
and neonatology unit at BMC, we explored exogenous and
endogenous risk factors for neonatal MDR-GNB sepsis, in-
cluding potential exogenous exposures in the household of
origin, in the hospital or from mothers, and endogenous ex-
posure (neonatal carriage). Results can be used to inform
case management, and to target infection prevention and
control measures to reduce case incidence.
Methods
The aim, design and setting of the study
A cross-sectional hospital-based study was conducted
between December 2018 and July 2019 aimed to deter-
mine, among other factors, the role of MDR-Gram-
negative bacteria (GNB) contaminating neonatal cots
and hands of mothers as possible role in transmission of
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bacteremia among neonates admitted to the neonatal
ICU (NICU) and neonatology unit at Bugando Medical
Centre (BMC), Mwanza, Tanzania. BMC is a tertiary, teach-
ing, consultancy and zonal referral hospital with an estimated
1000-bed capacity, serving Lake Zone regions (Mwanza,
Simiyu, Kagera, Shinyanga, Musoma, Tabora, Geita and
Kigoma) and a catchment population of 13 million people
(https://www.bugandomedicalcentre.go.tz/index.php). The
NICU was equipped with 15 neonatal cots (with no walking
space between cots), 15 trained nurses and 2 pediatricians.
In the neonatology unit, there were 36 cots about 0.5m
apart, 11 trained nurses and 4 pediatricians. When operating
at or above capacity, two neonates may share a cot (in both
units). In both units, the cots are irregularly disinfected be-
fore new occupancy by using 1:50 Dettol in water.
Sample size calculation and selection criteria
A minimum sample size for this study was 144 partici-
pants, which was calculated using Kish Leslie formula of
1965 [22], using an MDR-GNB prevalence of 10.5% [20].
Neonates admitted to NICU and neonatology unit with
signs and symptoms of infections as previous reported
by “WHO Young infants Study group” [23] and their
mothers were enrolled in this study. Neonates with signs
and symptoms of infection but either missing socio-
demographic information or a complete set of specimens
were excluded from the final analysis (n = 15). Partici-
pants (neonates and mothers) moving between the neo-
natal ICU and neonatology units were not re-enrolled.
Data and specimen collection
Structured questionnaires were used to obtain socio-
demographic and clinical information from study partici-
pants after the mother or guardian consented to partici-
pation. Neonatal blood samples, neonatal rectal swabs,
cot swabs and maternal hand swabs were collected.
About 1 ml of venous blood was collected into an in-
house made tryptone soy broth (TSB, 10 ml) by paedia-
trician; rectal swabs were collected by a trained medical
doctor; and bed swabs (in every new occupancy) and
mothers’ hand swabs specimens were collected. All swab
samples were collected using sterile cotton swabs pre-
moistened in sterile 0.85% physiological saline. All swab
specimens were transported to the laboratory in Amies
transport media (Amies, UK). In total, 800 specimens
(200 blood, 200 rectal swabs, 200 bed swabs and 200
mothers’ hands swabs) were collected. All specimens
were sent to the microbiology laboratory of the Cath-
olic University of Health and Allied Sciences for isola-
tion, identification, antibiotic susceptibility testing and
detection of MDR-GNB following in-house standard
operating procedures and international guidelines
such as Clinical and Laboratory Standard Institute
(CLSI, 2018) [24].
Definitions
In this study, GNB isolated from blood with resistance
to ceftriaxone and/or ceftazidime and GNB isolated from
rectal, bed and hand swabs grown on MacConkey agar
plates supplemented with 2 μg/ml cefotaxime (MCA-C)
were considered resistant to third generation cephalo-
sporins (r-3GCs) [11]. All GNB isolated from neonates’
blood, rectal, cots and mothers’ hands swab specimens
showing resistance to at least one antibiotic agent in
three different classes of antibiotics i.e., penicillins: ampi-
cillin (AMP), amoxicillin/clavulanate (AMC), piperacil-
lin/tazobactam (TZP); third generation cephalosporins
(3GCs): ceftriaxone (CRO), ceftazidime (CAZ) and/or
isolated on MCA-C; carbapenems: meropenem (MEM);
trimethoprim-sulfamethoxazole (SXT); aminoglycosides:
gentamicin (CN), amikacin (AK); fluoroquinolones: cip-
rofloxacin (CIP); tetracyclines: tetracycline (TET); and
/or polymyxins: colistin (CT), were termed as MDR-
GNB as previously reported [1, 2]. In this paper, isolates
exhibiting intermediate activities against antibiotics were
also termed as resistant.
Laboratory procedures
Bacterial isolation, identification and antibiotic
susceptibility testing Clinical specimens (blood):
Blood specimens in TSB bottles were incubated aerobic-
ally at 37 °C for 18–24 h upon receipt in the laboratory,
and before being inoculated onto in-house prepared 5%
sheep blood agar (SBA) and MacConkey agar (MCA)
plates (Oxoid, UK). SBA and MCA plates were incu-
bated aerobically at 37 °C for 18–24 h. However isolation
of Gram positive bacteria was not the objective of this
study, we purposely isolated and identified them and
their antibiotic susceptibility testing were performed to
guide rational antibiotic therapy for proper patients’
management only.
Isolated bacteria were identified by in-house prepared
conventional biochemical identification tests including
sugars fermentation, CO2 gas production and sulfur pro-
duction by triple sugar iron (TSI) test; sulfur production,
indole production and motility by sulfur-indole-motility
(SIM) test, urease production by urease test; utilization
of citrate as the sole source of energy by Simmons’ cit-
rate test; and oxidase production by oxidase test strips
as reported previously [25]. Kirby-Bauer disc diffusion
method was used for antibiotics susceptibility testing
(AST) on MHA plates [26]. Briefly, bacterial suspensions
equivalent to 0.5 McFarland turbidity standard solution
were prepared from a MacConkey subculture (arising
from a cultured clinical specimen and one isolated col-
ony from cefotaxime-supplemented MacConkey agar)
into sterile 0.85% physiological saline and then swabbed
on entire plates of MHA (Oxoid, UK). Ampicillin (AMP)
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10 μg, trimethoprim-sulfamethoxazole (SXT) 25 μg, ami-
kacin (AK) 30 μg, tetracycline (TE) 30 μg, piperacillin-
tazobactam (TZP) 110 μg, gentamicin (CN) 10 μg, cipro-
floxacin (CIP) 5 μg, amoxicillin-clavulanic acid (AMC)
30 μg, ceftriaxone (CRO) 30 μg, ceftazidime (CAZ) 30 μg,
meropenem (MEM) 10 μg and colistin sulfate (CT) 10 μg
antibiotic discs (Oxoid, UK) were seeded onto inoculated
MHA plates within 15 min. Interpretation of zones of in-
hibitions was done according to CLSI, 2018 [27]. Cefoxi-
tin (FOX) 30 μg discs were also included in AST
purposely for screening of potential Amp-C beta lacta-
mase producing GNB. Isolates exhibiting zone diameters
≤18mm were considered potential Amp-C beta lacta-
mase producers as reported previous [28, 29]. Zone di-
ameters for CT were interpreted as previous reported by
Galani et al. 2008 [30].
Colonization and contamination specimens (rectal,
cot and hand swabs): Immediately upon receipt of swab
specimens in the laboratory, these were inoculated on MCA-
C (Medochemie Ltd., Cyprus) for isolation of MDR-GNB.
Plates were incubated aerobically at 37 °C for 18–24 h. Con-
ventional biochemical identification tests were used for char-
acterisation of isolates to species levels as described earlier.
For AST, the antimicrobial panels and concentrations were
as described above, but beta-lactam antibiotic discs were ex-
cluded as isolation of resistant GNB involved the use of cefo-
taxime (beta-lactam) 2 μg/ml supplemented MCA plates.
CLSI (2018) [27] and Galani et al. 2008 [30] guidelines were
used for interpretation of zones of inhibitions.
Statistical analysis
STATA software version 13.0 was used for data analysis.
Continuous data were presented as median (interquartile
range) whereby categorical data were presented as per-
centages and fractions. Logistic regression and a step-
wise backwards model selection analysis was used to
determine risk factors and clinical symptoms for neo-
natal bacteremia in critical care units. A p value less
than 0.05 at 95% confidence interval was considered
statistical significant.
Results
Socio-demographic and clinical characteristics of
neonates admitted in neonatal ICU and neonatology unit
at BMC
Two-hundred neonates with median age (interquartile
range) of 1 (1–2) days were enrolled during this study
period, including 52.5% males and 47.5% females. Just
over half of the neonates (58%) were enrolled from the
neonatology unit. The median duration (interquartile
range) of a hospital stay was 7 (1–22.5) days. The major-
ity of neonates (73%), were enrolled after > 48 h of ad-
mission and 87.5% were on antibiotic treatment at the
time of clinical sampling and 24.5 and 84% had fever
and invasive devices during enrolment, respectively. In-
unit mortality was 9% in either unit (Table 1).
Culture results; blood, rectal, neonatal cots and mothers’
hands specimens
The prevalence of culture confirmed bacteremia was
34.5% of which 85.5% were GNB. About 93.2% of the
GNB isolated from positive blood cultures were r-3GCs.
The prevalence of GNB r-3GCs (grown MCA-C) colon-
izing neonates, contaminating neonates’ cots and
mothers’ hands was 43, 32 and 18.5%, respectively. K.
pneumoniae, Acinetobacter spp., E. coli and C. freundii
were frequently isolated from neonates’ blood and rectal
swab specimens suggesting that rectal colonization may
be the source of bacteremia. On the other hand, K.
pneumoniae, Acinetobacter spp. and E. aerogenes were
frequently isolated from neonates’ cots and mothers’
hands suggesting possibilities of mothers’ hands get con-
taminated when touching contaminated neonates’ cots.
The incidence of potential Amp-C beta lactamase pro-
ducers was higher among isolates contaminating neo-
nates’ cots and mothers’ hands, respectively (Table 2).
Percentage resistance of GNB isolated from blood culture
and GNB r-3GCs isolated from rectal, cots and hands
swabs specimens and respective magnitude of MDR-GNB
More than 90% of GNB isolated from blood exhibited
resistance to AMP, SXT, AMC and CRO. Isolates colon-
izing neonates and contaminating their cots had similar
frequencies of antibiotics resistance. Both exhibited
more than 95 and 70% resistance to STX and TE, re-
spectively. GNB contaminating mothers’ hands were
highly resistant to SXT (> 90%) and CN (> 85%). GNB
contaminating cots were more resistant to CT (67.2%)
compared to GNB isolated from blood (47.5%), rectal
swabs (52.6%) and mothers’ hand swabs (40.5%). Com-
parison of common antibiotic agents tested against all
isolates is reported below in Fig. 1. Over 90% of GNB
isolated from blood, rectal swabs, neonates’ cots and
hands of neonates’ mothers were MDR-GNB (resistant
to one or more antibiotic agents in three different clas-
ses of antibiotics), Fig. 2.
Factors associated with bacteremia in critical care units
On multivariate regression analysis, cyanosis
(OR[95%CI]: 3.13[1.51–6.51], p = 0.002), jaundice
(OR[95%CI]: 2.10[1.07–4.14], p = 0.031), number of inva-
sive devices (OR[95%CI]: 2.52[1.08–5.85], p = 0.031), ma-
ternal fever during pregnancy (OR[95%CI]: 2.17[1.17-
4.05], p = 0.014) and contaminated cot with MDR-GNB
(OR[95%CI]: 2.39[1.26–4.55], p = 0.008) found to be sig-
nificantly associated with bacteremia due to GNB. The
use of tap water only (OR[95%CI]: 2.12[0.88–5.09], p =
0.040) was protective for bacteremia due to GNB
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Table 1 Socio-demographic and clinical characteristics of neonates admitted in neonatal ICU and neonatology unit at BMC
Characteristics Frequency (n) Percentage (%)
Sex (N = 200) Females 95 47.5
Males 105 52.5
Unit (N = 200) Neonatology unit 116 58
Neonatal ICU 84 42
Keeping livestock at home (N = 200) Yes 37 18.5
No 163 81.5
Keeping pet* at home (N = 200) Yes 74 37
No 126 63
Water sources (N = 200) Open sources 14 7
Tap water 175 87.5
Both 11 5.5
Drinking water treatment (boiling) (N = 200) Yes 123 61.5
No 77 38.5
Fever during sampling (N = 200) Yes 35 17.5
No 165 82.5
Type of fever (N = 35) Hypothermia 16 45.7
Hyperthermia 19 54.3
Heart rate (N = 192) Normal 145 75.5
Abnormal 47 24.5
Breathing/respiration rate (N = 191) Normal 145 75.9
Abnormal 46 24.1
Oxygen saturation (N = 192) Normal 142 73.9
Abnormal 50 26.1
Prematurity status (N = 200) Yes 144 72.0
No 56 28.0
Length of hospital stay at enrollment (N = 200) < 48 h 143 71.5
> 48 h 57 28.5
On antibiotics at the time of clinical sampling (N = 200) Yes 175 87.5
No 25 12.5
Type of antibiotic (N = 175) Ceftriaxone 3 1.7
Gentamicin 166 94.9
Ampicillin/ampiclox 171 97.7
Presence of invasive device at sampling (N = 200) Yes 166 83.0
No 34 17.0
Type of invasive device (N = 166) Urinary catheter (UC) 5 3.0
Nasogastric tube (NT) 125 75.3
Intravenous line (IV line) 161 96.9
IV line + NT 117 70.5
IV line + NT + UC 5 3.0
Convulsion (N = 192) Yes 7 3.6
No 185 96.4
Paleness (N = 200) Yes 22 11.0
No 178 89.0
Meconium stained (N = 200) Yes 33 16.5
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(Table 3). In addition, neonates colonized with MDR-
GNB, their cots were also significantly contaminated
with MDR-GNB (OR[95%CI]: 2.43[1.33–4.47], p =
0.004).
Phenotypic similarities of MDR-GNB between blood isolates
and rectal colonization or bed contamination or mother’s
hand contamination
A proportion of 11.7% (7/59), 8.5% (5/59) and 6.8% (4/
59) MDR-GNB isolates causing bacteremia had identical
bacteria species with MDR-GNB colonizing neonates,
contaminating neonates’ beds and contaminating hands
of neonates’ mothers, respectively (Table 4).
Discussion
Slightly majority (52.5%) of neonates enrolled in this
study were males with overall median duration of stay in
the respective unit of 7 days however 1 day was the
shortest stay and about 23 days was the longest stay. The
majority (73%) were enrolled in this study after 48 h of
being admitted in the respective unit, suggesting that
these neonates developed HCAIs however this was not
statistically significant. The majority (87.5%) of neonates
were also on antibiotics use during clinical sampling,
which may have reduced the sensitivity of culture based
diagnostic tests mainly blood culture [31, 32].
In the current study, about one third of neonates had
positive culture confirmed bacteremia, despite the fact
that a large proportion of neonates were already
receiving treatment, which may reduce recover of bac-
teria from blood culture [31, 32]. Over three quarters of
the isolated bacteria from blood cultures were Gram-
negative bacteria, of which K. pneumoniae, Acinetobacter
spp. and E. coli were frequently isolated. Similar results
were reported previously in the same setting, BMC [11]
and elsewhere [33].
Significantly large proportion of GNB isolated from
blood culture were resistant to 3GCs. In addition, almost
95% of GNB isolated from blood culture and GNB r-
3GCs isolated from rectal, cots and mothers’ hands
swabs were found to be MDR-GNB. Generally, all MDR-
GNB isolated from blood, rectal swabs, bed swabs and
hand swabs were more frequently resistant to commonly
used antibiotics than uncommon antibiotics. Commonly
used antibiotics, such as ampicillin, trimethoprim-
sulfamethoxazole, tetracycline, gentamicin, ciprofloxacin,
amoxicillin-clavulanate and ceftriaxone, are used as first-
and second-line treatment options and as prophylaxis
[34]. The MDR-GNB showed low prevalences of resist-
ance against amikacin and meropenem. Regulated use of
these antibiotics in Tanzania, as meropenem is reserved
for treatment of infections with MDR bacteria and ami-
kacin for treatment of tuberculosis and actinemycetoma,
may explain the low bacterial resistance against them
[34]. Despite the fact that colistin sulfate is not regis-
tered and available for clinical use in Tanzania [34],
GNB isolated in our settings exhibited higher percent-
ages of resistance against it. In the same region
Table 1 Socio-demographic and clinical characteristics of neonates admitted in neonatal ICU and neonatology unit at BMC
(Continued)
Characteristics Frequency (n) Percentage (%)
No 167 83.5
Resuscitation (N = 192) Yes 128 66.7
No 64 33.3
Poor feeding (N = 192) No 59 30.7
Yes 133 69.3
Jaundice (N = 200) Yes 64 32.0
No 136 68.0
Cyanosis (N = 200) Yes 53 26.5
No 147 73.5
Nasal flaring (N = 200) Yes 111 55.5
No 89 44.5
Chest indrawing (N = 200) Yes 78 39.0
No 122 61.0
Discharging umbilical cord (N = 200) Yes 60 30.0
No 140 70.0
Outcomes (N = 200) Death 18 9.0
Discharge 182 91.0
Notes: IQR interquartile range; Median age (IQR) in days: 1 (1–2) days; Median days (IQR) of hospital stay: 7 (1–22.5) days and *pet = dog and/or cat
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(Tanzania), one study reported a 66.1% resistance to co-
listin sulfate among Enterobacteriaceae colonizing hotel
employees [35] and another study reported a 95.6% re-
sistance to colistin sulfate among Campylobacter spp.
isolated from humans [36]. The use of colistin sulfate in
veterinary medicine in Tanzania [37], suggests that, vet-
erinary use of antimicrobials may be a key driver of the
AMR problems in environment as well as clinical set-
tings as observed in this study.
This current study examined risk factors of bacteremia
due to GNB based on pre-admission history, neonatal
clinical presentation and potential transmission in the
unit; neonatal ICU and/or neonatology unit. Therefore,
this study found that, domestic use of tap water only as
pre-admission history is protective factor (p = 0.040) for
bacteremia. Treatment of water for domestic use by sand
filtrations at water treatment plant in Mwanza [38], may
have been played an effective role of reducing the abso-
lute concentrations of MDR-bacteria and antibiotic re-
sistance genes (ARGs) from contaminated source [39] as
reported by Zhang et al, 2016 [40]. Thus, admitted
neonates with parents’ domestic use of water from open
sources such as dams and lake, should be screened for
possibilities of bacteremia due to GNB. Maternal fever
during pregnancy is the manifestation of systemic in-
flammations which may be due to infections such as
BSIs, UTIs, infections of the amniotic fluid, or foetal
membranes or placenta. Apart from causing maternal
complications, these infections may be associated with
early onset of neonatal complications such as bacteremia,
pneumonia and meningitis [54]. Neonates with clinical
presentations of jaundice (p = 0.031) and cyanosis (p =
0.002) were significantly culture confirmed positive for
bacteremia due to GNB. Sepsis induces host production
of cytokines (interleukin-1β, tumor necrosis factor-α, ni-
tric oxide and reactive oxygen species), which result in
dysregulated systemic inflammatory response associated
with multiple organ damage and shock e.g., cardiac dys-
function and hepatocellular injury [41]. Cardiac dysfunc-
tion, a cardiopulmonary condition, causes shortage supply
of oxygenated haemoglobin (blood) reaching body parts
resulting to cyanosis [42]. Further, hepatocellular injury
Table 2 Culture results: blood, rectal swab, cot swab and mothers’ hands swab specimens
Variables Blood culture Rectal culture Cots culture CGs’ hands culture
n % n % n % n %
Culture results Positive 69 34.5 86 43 64 32 37 18.5
Negative 131 65.5 114 57 136 68 163 81.5
Classification of positive blood culture Gram-positive 10 14.5 NA NA NA NA NA NA
Gram-negative 59 85.5 NA NA NA NA NA NA
Genus and species of isolated bacteria# K. pneumoniae 28 47.5 49 45.4 18 28.1 17 45.9
Acinetobacter spp 19 32.2 23 21.3 35 54.7 8 21.6
E. coli 5 8.5 14 12.9 1 1.6 2 5.4
C. freundii 3 5.1 10 9.3 3 4.7 1 2.7
E. aerogenes 1 1.7 4 3.7 6 9.4 5 13.5
Others* 3 5.1 8 7.4 1 1.6 4 10.8
Resistant to 3GCs (blood culture only) Positive 55 93.2 NA NA NA NA NA NA
Negative 4 6.8 NA NA NA NA NA NA
Amp-C beta lactamase (FOX≤18 mm) Positive 23 38.9 50 46.3 48 75 22 59.5
Negative 36 61.1 58 53.7 16 25 15 40.5
Genus and species of potential Amp-C beta lactamase producers Acinetobacter spp 13 56.5 22 44 34 70.8 8 36.4
C. freundii 3 13.0 7 14 3 6.3 1 4.5
K. pneumoniae 2 8.7 12 24 4 8.3 5 22.7
E. coli 2 8.7 2 4 1 2.1 1 4.5
Others** 3 12.9 7 14 6 12.5 7 31.8
#Blood culture: GNB only
*Blood culture: E. cloacae (n = 1), Salmonella spp. (n = 1) and unidentified GNB (n = 1)
*Rectal swabs: E. cloacae (n = 2), Shigella spp. (n = 2), P. aeruginosa (n = 1), Salmonella spp. (n = 1), K. oxytoca (n = 1) and P. agglomerans (n = 1)
*Neonatal cot swabs: A. hydrophila (n = 1)
*Mothers’ hands swabs: E. cloacae (n = 3), K. oxytoca (n = 1)
**Blood culture: E. aerogenes (n = 1), Salmonella spp. (n = 1) and unidentified GNB (n = 1)
**Rectal swabs: E. aerogenes (n = 3), E. cloacae (n = 2), P. aeruginosa (n = 1) and Salmonella spp. (n = 1)
**Neonatal cot swabs: E. aerogenes (n = 6)
**Mothers’ hands swabs: E. aerogenes (n = 4), E. cloacae (n = 2) and K. oxytoca (n = 1)
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and bacterial products which causes hemolysis e.g., cytoly-
sins, promotes elevation of serum bilirubin leading to
jaundice [43]. Therefore, cyanosis and jaundice can be used
as accompanying markers in diagnosis of sepsis among neo-
nates in critical care units. Empirical antibiotic therapy, may
also be initiated after blood sample collection if neonate pre-
sents clinical signs and symptoms of cyanosis and jaundice
and whilst awaiting for microbiological culture results. How-
ever, third line antibiotic therapy is recommended at this set-
ting as significant higher proportion of GNB isolated from
blood culture are resistant to 3GCs and are MDR-GNB,
respectively.
Contaminated cots (p = 0.008) and multiple invasive de-
vices (p = 0.031) suggests potential transmission in the
units as they significantly associated with bacteremia.
Similar findings were reported elsewhere [44–46]. Invasive
devices e.g., intravascular lines required for venous access
for administration of medications among critically ill may
also provide portal of entry of potential pathogenic bac-
teria if inserted through contaminated skin [45]. Contami-
nated inanimate surfaces in the patient’s zone (patient’s
immediate surroundings) such as cots increases the risk of
healthcare associated infections (HCAIs) mostly among
patients with multiple invasive devices [46]. Contaminated
hands of HCWs and/or CGs play the major role in cross-
transmitting pathogens from contaminated inanimate sur-
faces to patients resulting to HCAIs [46].
As previously reported [20], rectal colonization with
MDR-GNB among neonates in critical care units is high
at BMC. This study (43%) and a another study (54.6%)
in 2016 [20] found a higher prevalence of neonatal rectal
colonization with MDR-GNB than a study (25.4%) con-
ducted in 2013 [19] at BMC. Trends towards increasing
prevalence of MDR colonization likely reflect increasing
rates of antibiotic resistance. A study conducted from
2013 to 2015 [47] observed high resistance of GNB to
3GCs causing infections at the same setting, Mwanza,
Tanzania. Similarly to other studies [19, 48, 49], MDR-
K. pneumoniae and Acinetobacter spp. were the most
common GNB r-3GCs and potential Amp-C beta-
lactamase producers, respectively, predominantly colon-
izing neonates in critical care units in our study.
A large proportion (32%) of neonates’ cots were con-
taminated with MDR-GNB, significantly (p = 0.004) as-
sociated with rectal colonization of the current
neonates occupying the cots. Similar observation, large
proportion of inanimate surfaces contamination, was
reported previous in similar hospital in Mwanza,
Tanzania [21]. The capacity for biofilm formation and
multiple mechanisms of resistance to antibiotics, heavy
Fig. 1 Comparison of percentage resistance of isolates from blood, rectal swab, cot swabs and mothers’ hands swab specimens against antibiotic
agents tested in common
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metals and detergents/disinfectants enables long dur-
ation survival of contaminating bacteria on inanimate
surfaces including cots [46, 50, 51]. Patients’ immediate
inanimate surfaces, such as neonatal cots, can be dir-
ectly contaminated by microorganisms shedded from
infected and/or colonized patients as observed in this
study that, contamination of neonatal cots is signifi-
cantly associated with neonate’s rectal colonization.
Microorganisms, may also be cross-transmitted to con-
taminate inanimate surfaces through contaminated
hands of healthcare workers (HCWs) and caregivers
(CGs) [46]. Overcrowding of neonates, unacceptably
small distances between cots and infrequent decontam-
ination of neonates’ cots as observed by this study may
lead to increased contamination of neonates’ cots in
this settings. Furthermore, other factors including con-
centration of decontaminant, types of surface contam-
inating bacteria, contact time with surfaces, and care of
cleaning cloth are reported associated with high levels
of contamination of inanimate surfaces [39]. CDC
recommends regularly decontamination of reusable
cleaning cloths and mops [40]. Further, surfaces con-
taminated with MDR-GNB were found a significant risk
factor for bacteremia in critical care units as reported
previously [52]. A patient occupying a bed or room
after an MDR colonized or infected patient, which was
improperly (or not) disinfected, has an increased risk of
acquiring infection due to MDR bacteria [52].
Almost one fifth (18.5%) of mothers’ hands were
contaminated with GNB r-3GCs in this setting. High
proportion (94.6%) of GNB -3GCs, were MDR-GNB.
Before touching and breastfeeding their neonates,
mothers wash their hands with running tap water and
detergents. It is possible that handwashing practices
are insufficient or they acquired contamination when
touching contaminated surfaces such as beds and/or
during other contact with their baby such as diaper
changing, as significant number of neonates and beds
were colonized and contaminated, respectively. The
hands of healthcare workers (HCWs) or caregivers
(CGs) after touching contaminated inanimate surfaces
such as beds act as vehicles in cross-transmitting
MDR bacteria to patients [53]; consequently resulting
to patients’ acquisition of infections due to MDR
bacteria.
This study observed seven, five and four pairs out
of 59 pairs of MDR-GNB isolated from neonatal
blood having similar species with MDR-GNB isolated
Fig. 2 Proportion of MDR-GNB isolated from neonates’ blood, rectal, cots and mothers’ hands. The number of isolates in indicated in brackets
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Table 3 Factors associated with neonatal bacteremia in critical care units
Variable All
participants
Bacteremia by GNB Univariate Multivariate
N = 59 (%) P value OR [95%CI] P value
Sex (N = 200)
Females 95 28 (29.5) 0.994 1.01 [0.54-1.88] 0.972
Males 105 31 (29.5)
Unit (N = 200)
Neonatology unit 116 33 (28.5) 0.702 1.13 [0.60-2.11] 0.700
Neonatal ICU 84 26 (30.9)
Length of hospital stay at enrolment (N = 200)
<48 hours 143 37 (25.9) 0.075 1.80 [0.94-3.46] 0.077
>48 hours 57 22 (39.3)
Livestock keeping at home (N = 200)
No 163 48 (29.5) 0.973 1.02 [0.41-2.53] 0.968
Yes 37 11 (29.7)
Keeping pet* at home (N = 200)
No 126 37 (29.4) 0.956 0.98 [0.47-2.07] 0.973
Yes 74 22 (29.7)
Source of water (N = 200)
Both 11 7 (63.6) 0.038 2.12 [0.88-5.09] 0.040
Open sources 14 4 (28.6)
Tap water 175 48 (27.4)
Body temperature (N = 200)
Normal 165 44 (26.7) 0.056 1.55 [0.95-2.55] 0.081
Hypo/hyperthermia 35 15 (42.9)
On antibiotic during sampling (N = 200)
No 25 10 (40.0) 0.218 0.50 [0.18-1.37] 0.180
Yes 175 49 (28.9)
Presence of invasive device (N = 200)
No 34 10 (29.4) 0.990 0.94 [0.36-2.49] 0.909
Yes 166 49 (29.5)
Number of invasive devices (N = 200)
≤1 122 42 (34.4) 0.058 2.52 [1.08-5.85] 0.031
≥2 78 17 (21.8)
Prematurity status (N = 200)
No 56 21 (37.5) 0.124 0.59 [0.30-1.17] 0.135
Yes 144 38 (26.4)
Resuscitation (N = 192)
No 64 17 (26.6) 0.734 0.78 [0.35-1.79] 0.569
Yes 128 37 (28.9)
Poor feeding (N = 192)
No 59 14 (23.7) 0.368 1.07 [0.41-2.85] 0.885
Yes 133 40 (30.1)
Convulsion (N = 192)
No 185 50 (27.0) 0.082 4.60 [0.88-23.78] 0.069
Yes 7 4 (57.1)
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from rectal colonization, cots contamination and
mothers’ hands contamination, respectively. This ob-
servation may suggests possible cross-transmission of
MDR-GNB between these niches [46]. Further,
screening of multiple isolates per sample and molecu-
lar typing techniques with greater resolution, e.g.
multi-locus sequence typing, pulse-field gel electro-
phoresis (PFGE) or, ideally, whole genome sequencing
(WGS) will be important in determining clonal simi-
larities of these isolates.
Conclusion
Our study found high prevalence of antimicrobial resistant
Gram-negative bacteria in sepsis patients in neonatal ICU
and neonatology unit. Additionally, high prevalence of
MDR-GNB colonizing neonates, contaminating hands of
neonates’ mothers and contaminating neonates’ immedi-
ate environment, their cots, is extremely concerning. As a
result, this study provides evidence for immediate recom-
mendation for: better and frequently (e.g., weekly) decon-
tamination on neonates’ cots; information campaign for
Table 3 Factors associated with neonatal bacteremia in critical care units (Continued)
Variable All
participants
Bacteremia by GNB Univariate Multivariate
N = 59 (%) P value OR [95%CI] P value
Paleness (N = 200)
No 178 52 (29.2) 0.801 1.29 [0.48-3.53] 0.607
Yes 22 7 (31.8)
Jaundice (N = 200)
Negative 136 34 (25.0) 0.043 2.10 [1.07-4.14] 0.031
Positive 64 25 (39.1)
Cyanosis (N = 200)
Negative 147 34 (23.1) <0.001 3.13 [1.51-6.51] 0.002
Positive 53 25 (47.2)
Nasal flaring (N = 200)
Negative 89 24 (26.9) 0.482 0.86 [0.42-1.76] 0.688
Positive 111 35 (31.5)
Chest indrawing (N = 200)
Negative 122 31 (25.4) 0.114 1.83 [0.94-3.57] 0.076
Positive 78 28 (35.9)
Discharging umbilicus (N = 200)
Negative 140 40 (28.6) 0.660 1.55 [0.755-3.18] 0.232
Positive 60 19 (31.7)
Rectal colonization (N = 200)
Negative 114 28 (24.6) 0.079 1.82 [0.93-3.57] 0.079
Positive 86 31 (36.1)
Cot contamination (N = 200)
Negative 136 32 (23.5) 0.008 2.39 [1.26-4.55] 0.008
Positive 64 27 (42.2)
Mother’s hand contamination (N = 200)
Negative 163 49 (30.1) 0.715 0.84 [0.36-1.93] 0.684
Positive 37 10 (27.0)
Maternal fever during pregnancy (N = 200)
No 105 23 (21.9%)
Yes 95 36 (37.9%) 0.013 2.17 [1.17-4.05] 0.014
Outcome (N = 200)
Discharge 182 52 (28.6) 0.363 1.63 [0.57-4.57] 0.355
Death 18 7 (38.9)
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mothers on potential cross-transmission of MDR bacteria
in causing bacteremia through contaminated hands; and
prioritization of 3rd line treatments based on clinical
(cyanosis and jaundice) and pre-admission history (do-
mestic use of open water sources) in neonatal intensive
care and neonatology units at this setting. Furthermore, a
follow-up study is recommended to determine the inci-
dence of bacteremia after proper decontamination proto-
cols are followed up and mothers are educated on
infection control practices as recommended.
Abbreviations
AMC: Amoxicillin-clavulanic acid; AMP: Ampicillin; ARGs: Antibiotic resistant
genes; AST: Antibiotic susceptibility testing; BMC: Bugando Medical Centre;
CAZ: Ceftazidime; CG: Care giver; CIP: Ciprofloxacin; CLSI: Clinical and
Laboratory Standards Institute; CN: Gentamicin; CRO: Ceftriaxone; CT: Colistin
sulfate; DDS: Double Disk Synergy; GNB: Gram-negative bacteria;
HCAIs: Healthcare associated infections; HCW: Health care worker;
ICU: Intensive care unit; IPC: Infection prevention and control; MCA-
C: MacConkey Agar supplemented with cefotaxime; MDR: Multidrug
resistance; NICU: Neonatal ICU; r-3GCs: resistant to third generation
cephalosporins; SBA: Sheep blood agar; TSI: Triple sugar iron; UTI: Urinary
tract infection; 3GC: Third generation cephalosporin
Table 4 AST profiles as a measure of phenotypic similarities between pairs of isolates of MDR-GNB isolated from blood and MDR-
GNB isolated from rectal, bed and mothers’ hands swabs
Phenotypic pairs ID Isolates Sources Comparisons and interpretations of inhibition zones (mm)
SXT TE CN CIP MEM CT
Blood vs rectal colonization
11.9% (7/59)
068CL K. pneumoniae Blood 6 (R) 20 (S) 10 (R) 34 (S) 30 (S) 13 (I)
Rectal 6 (R) 20 (S) 10 (R) 32 (S) 30 (S) 12 (I)
233CL E. aerogenes Blood 6 (R) 8 (R) 15 (S) 20 (I) 32 (S) 13 (I)
Rectal 6 (R) 12 (I) 17 (S) 22 (S) 28 (S) 13 (I)
275CL K. pneumoniae Blood 6 (R) 24 (S) 14 (I) 28 (S) 28 (S) 13 (I)
Rectal 6 (R) 22 (S) 14 (I) 28 (S) 32 (S) 14 (S)
285CL K. pneumoniae Blood 6 (R) 6 (R) 6 (R) 17 (I) 30 (S) 15 (S)
Rectal 6 (R) 6 (R) 8 (R) 20 (I) 30 (S) 15 (S)
185CL Acinetobacter spp Blood 22 (S) 18 (S) 20 (S) 22 (S) 32 (S) 13 (I)
Rectal 6 (R) 6 (R) 10 (R) 10 (R) 23 (S) 14 (S)
083CL K. pneumoniae Blood 6 (R) 20 (S) 10 (R) 34 (S) 30 (S) 13 (I)
Rectal 6 (R) 20 (S) 8 (R) 32 (S) 30 (S) 11 (R)
282CL K. pneumoniae Blood 6 (R) 22 (S) 15 (S) 27 (S) 30 (S) 16 (S)
Rectal 6 (R) 23 (S) 16 (S) 27 (S) 28 (S) 16 (S)
Blood vs bed contamination
8.5% (5/59)
249CL K. pneumoniae Blood 6 (R) 23 (S) 15 (S) 26 (S) 12 (R) 11 (R)
Bed 6 (R) 20 (S) 14 (I) 27 (S) 29 (S) 12 (I)
241CL Acinetobacter spp Blood 6 (R) 6 (R) 16 (S) 6 (R) 10 (R) 13 (I)
Bed 6 (R) 6 (R) 10 (R) 13 (R) 8 (R) 14 (S)
187CL Acinetobacter spp Blood 6 (R) 8 (R) 15 (S) 25 (S) 27 (S) 13 (I)
Bed 6 (R) 6 (R) 24 (S) 6 (R) 6 (R) 13 (I)
242CL Acinetobacter spp Blood 24 (S) 18 (S) 14 (I) 30 (S) 28 (S) 14 (S)
Bed 6 (R) 6 (R) 14 (I) 28 (S) 6 (R) 13 (I)
243CL Acinetobacter spp Blood 6 (R) 25 (S) 24 (S) 30 (S) 15 (I) 13 (I)
Bed 6 (R) 6 (R) 15 (S) 27 (S) 6 (R) 15 (S)
Blood vs mother contaminated hand
6.8% (4/59)
068CL K. pneumoniae Blood 6 (R) 20 (S) 10 (R) 34 (S) 30 (S) 13 (I)
Hand 6 (R) 11 (R) 6 (R) 22 (S) 26 (S) 15 (S)
083CL K. pneumoniae Blood 6 (R) 12 (I) 12 (R) 32 (S) 30 (S) 13 (I)
Hand 6 (R) 22 (S) 6 (R) 28 (S) 28 (S) 14 (S)
186CL K. pneumoniae Blood 6 (R) 18 (S) 10 (R) 28 (S) 28 (S) 14 (S)
Hand 6 (R) 6 (R) 8 (R) 17 (I) 28 (S) 12 (I)
294CL K. pneumoniae Blood 6 (R) 6 (R) 6 (R) 32 (S) 32 (S) 14 (S)
Hand 6 (R) 22 (S) 6 (R) 15 (R) 28 (S) 16 (S)
Notes: SXT trimethoprim-sulfamethoxazole, TE tetracycline, CN gentamicin, CIP ciprofloxacin, MEM meropenem and CT colistin sulfate, S sensitive, I intermediate
and R resistant
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